The FDA Peptide Crackdown: Regulatory Capture, Not Patient Safety
BPC-157, GHK-Cu, MOTS-c, and a dozen other peptides have been pushed off the legal compounding market. The justification is safety. The reality is regulatory capture. Here is the honest read.
Enclomiphene: The TRT Alternative That Keeps You Fertile (Full Protocol)
Enclomiphene is the most underrated tool in men’s hormone optimization. Full protocol, real case studies, side effects, and when it beats TRT outright.
Why I Built My Supplement Empire in Thailand (And Won’t Move Back)
Tony Huge on why he runs Enhanced Labs and his media operation out of Thailand — regulatory freedom, talent, lifestyle, and the FDA reality.
The FDA Peptide Crackdown: Who Wins, Who Loses, and Where Supply Is Going
The FDA quietly killed access to BPC-157, CJC-1295, and other compounded peptides. Here is what is really happening and why the safety argument falls apart.
The Compounding Pharmacy Crackdown Is Coming — Here’s What I’m Stockpiling Before the Door Closes
The era of cheap, accessible compounded peptides through 503A pharmacies is ending. If you’ve been getting BPC-157, TB-500, GHK-Cu, semaglutide, tirzepatide, or any other compounded peptide from a small US compounding pharmacy on a doctor’s prescription — the window for that pipeline is closing faster than most people realize. I’m going to walk you through […]
The Bloodwork Confession: Why I Publish My Labs and Why the Enhanced Industry Won’t
Every enhanced athlete should publish quarterly bloodwork. Almost none do. Tony’s case for radical transparency, the markers that actually matter, and his most recent panel — unedited.